OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

OncoDaily
Apr 26, 2024, 15:14 | Blog
Stephen V Liu: Narjust Florez at TexasLung24 explains why and how social media can help the practicing oncologist
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared a post on…
Apr 26, 2024, 14:53 | Positive
Cristiane Bergerot: Grateful to receive a heartwarming email from ⁦ASCO, thanking me for my contributions during Global Volunteer Month
Cristiane Bergerot shared a post on X/Twitter: "Grateful to receive a heartwarming email from ⁦ASCO,…
Apr 26, 2024, 14:15 | Drugs
Carl Ola Landgren: With Minimal Residual Disease (MRD) as an early endpoint for accelerated approval of new multiple myeloma drugs, patients access to new therapies will be much quicker
Apr 26, 2024, 13:58 | Societies
Common Sense Oncology leadership team is having its first annual meeting in Montreal
Common Sense Oncology shared a post on X/Twitter: "Common Sense Oncology leadership team is having…
Apr 26, 2024, 13:29 | Blog
Mark Lewis: How one of my patients described chemo cycles and oh my
Quoting Mark Lewis on X/Twitter: "This is how one of my patients described chemo cycles…
Apr 26, 2024, 12:49 | Blog
The key take aways from BTOG24 - Oncogene Cancer Research
Oncogene Cancer Research shared on LinkedIn: "What are the key take aways from BTOG24? Here, Drs.…
Apr 26, 2024, 12:41 | Blog
Dickson Daniel: Young people getting involved in cancer Awareness is super important
Dickson Daniel, Team Lead at Onco Intelligence, shared on LinkedIn: "Young people getting involved in cancer…
Apr 26, 2024, 12:20 | Blog
World Immunization Week - Union for International Cancer Control
Union for International Cancer Control (UICC) shared on LinkedIn: "Cervical cancer is the fourth most common…
Apr 26, 2024, 12:05 | Blog
The final day of GIORNATE AIEOP 2024!
AIEOP: Italian Association of Pediatric Hematology and Oncology shared on LinkedIn: "That concludes the final…
Apr 26, 2024, 12:00 | Blog
Vivek Subbiah: Window of opportunity (WOO) studies across cancer subtypes by Barbara Pistilli
Vivek Subbiah shared a post on X/Twitter: "Window of opportunity (WOO) studies across cancer subtypes?…
Apr 26, 2024, 11:57 | Blog
Myriam Chalabi: What happens in Zurich….goes to ESMO25
Myriam Chalabi shared on X/Twitter: ''What happens in Zurich….goes to ESMO25! Fantastic meeting and discussions…
Apr 26, 2024, 11:43 | Blog
Timon Vandamme: 20.04.2024 is all about neuroendocrine cancer at ENDIMET2024
Timon Vandamme, Senior Clinical Investigator at Research Foundation – Flanders (FWO) and Independent Academic Staff…
Apr 26, 2024, 11:17 | Insight
Satya Prakash Yadav: Europe in 2022 BMT and Cell Therapy trends
Satya Prakash Yadav, Director of Pediatric Hemato-Oncology and Bone Marrow Transplant at Medanta, shared on…
Apr 26, 2024, 11:10 | Blog
Vivek Subbiah: The world of oncology converges in Zurich, Switzerland!
Vivek Subbiah posted on X/Twitter: ''The world of oncology converges in Zurich, Switzerland! Such an…
Apr 26, 2024, 11:05 | Blog
Paolo Tarantino: Wonderful experience to brainstorm about the agnostic potential of ADCs with Roberto Carmagnani Pestana
Paolo Tarantino, Research Fellow at Dana Farber Cancer Institute, shared a post by Roberto Carmagnani Pestana,…
Apr 26, 2024, 11:03 | Blog
Vivek Subbiah: FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
Vivek Subbiah shared a post on X: "FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive…
Apr 26, 2024, 10:19 | Blog
Carmen Monge-Montero: Honoured to feature an interview with Iara Mantiñán Búa from Spain
Carmen Monge-Montero, Researcher at Youth Cancer Europe and Founder of Monge Consultancy, shared on LinkedIn: "Hi…
Apr 26, 2024, 10:13 | Blog
Egor Matnurov explains immunogenic cell death - The Babak Lab
Maria Babak, Assistant Professor at City University of Hong Kong, shared a post by The Babak…
Apr 26, 2024, 10:07 | Drugs
Rami Manochakian: U.S. FDA approves adjuvant Alectinib in patients with stage IB-IIIA ALK+Non-Small Cell Lung Cancer
Rami Manochakian, Associate Professor and Thoracic Oncologist at Mayo Clinic, shared on X/Twitter: ''HOT OFF…
Apr 26, 2024, 10:00 | Insight
Biagio Ricciuti: Our work on long-term outcomes to PD-1 monotherapy by increasing PD-L1 levels in NSCLC is out in JTO and JTO CRR
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter: ''Our work on long-term…
Apr 26, 2024, 09:41 | Blog
Vivek Subbiah: Read a recap of 'AI at the Interface' at AACR24 plenary session in AACR Annual Meeting News
Vivek Subbiah posted on X/Twitter: ''Yes! The future IS now! 'AI at the Interface: Accelerating…
Apr 26, 2024, 09:34 | Blog
Samantha Ziegel: That rainy day contact you might need one day
Samantha Ziegel, Platform Lead at Perficient, shared a post on LinkedIn: ''That rainy day contact…
Apr 26, 2024, 09:26 | Insight
Chul Kim: Thoughtful discussion and great talk by Rachel Sanborn about recent approval of FLAURA2
Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared a post on X/Twitter: ''First-line treatment…
Apr 26, 2024, 09:10 | Blog
Chiara Mercinelli: What a dynamic all-female collaboration in uro-oncology
Chiara Mercinelli, Fellow Research Oncology Resident at IRCCS San Raffaele, shared a post on X/Twitter:…
Apr 26, 2024, 09:02 | Career
Tarek Haykal: I just accepted an offer to join the incredible University of Michigan  as faculty and Melanoma medical oncologist
Tarek Haykal, Assistant Professor and Medical Oncologist at the Ohio State University, shared a post…
Apr 26, 2024, 08:52 | Blog
Yuksel Urun: A brilliant perspective and a lesson-laden approach from Bernard Escudier, Gustave Roussy
Yuksel Urun, Professor in Department of Medical Oncology at Ankara University School of Medicine, shared…
Apr 26, 2024, 08:46 | Blog
Kimryn Rathmell: They are the future of our field
Kimryn Rathmell, Director of the National Cancer Institute, shared a post on X/Twitter: ''I had the…
Apr 26, 2024, 08:37 | Blog
Karen Knudsen: A huge thank you to the 74 CEOs who participated in our one-day Fit2BeCancerFree CEO Challenge
Karen Knudsen shared on X/Twitter: ''A huge thank you to the 74 CEOs who participated in…
Apr 26, 2024, 08:22 | Blog
Yuksel Urun: Europe emphasized program implementation for patient and organization support
Yuksel Urun, Professor in Department of Medical Oncology at Ankara University School of Medicine, shared…
Apr 26, 2024, 08:16 | Blog
Brett Hoffland: April is testicular cancer awareness month, so guys make sure you prioritize monthly self-exams
Brett Hoffland, Weekend anchor/reporter at KSTP-TV (Hubbard Broadcasting), shared on their X/Twitter: ''4 years ago…
Apr 26, 2024, 08:09 | Blog
Hagop Kantarjian: The results of the first clinical trial to explore activin receptor ligand traps of drugs in MF
Hagop Kantarjian, Leukaemia professor and Chair at MD Anderson Cancer Center, shared on X: ''Activin receptor…
Apr 26, 2024, 08:07 | Blog
Shushan Hovsepyan: Join us for our next 5-minute Sarcoma Talk on OncoDaily!
Shushan Hovsepyan, shared a post on LinkedIn: “Join us for our next 5-minute Sarcoma Talk on…
Apr 26, 2024, 07:57 | Blog
Arunah Chandran: Circling back to University of Malaya as an Elite Fellow
Arunah Chandran, Public Health Officer at IARC/WHO, shared on LinkedIn: "Circling back to University of…
Apr 26, 2024, 07:37 | Blog
Meet the Author Amin H. Nassar by Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer shared on X/Twitter: "Meet the Author: Amin H. Nassar, a medical…
Apr 26, 2024, 07:04 | Blog
Rudi Schmidt: The PD1/PD-L1 checkpoint pathway is almost exclusively associated with cancer and immunotherapies
Rudi Schmidt, Chief Operating Officer at Institute for Healthier Living Abu Dhabi, shared on LinkedIn:…
Apr 26, 2024, 06:33 | Opinion
Emma Groarke on Ruxolitinib Study for Refractory T-LGL Leukemia from France
Emma Groarke, Hematologist at the National Institutes of Health (NIH), shared a post on X/Twitter:…
Apr 26, 2024, 06:18 | Blog
Aaron Goodman: This is nice paper that goes over differentiation syndrome associated with IDH1/2 inhibitors
Aaron Goodman shared on X: “This is nice paper that goes over differentiation syndrome associated…
Apr 26, 2024, 05:21 | Blog
Katie Coleman: Finding Meaning in Hospital Bands on the Journey to NED
Katie Coleman, Founder of Chromophobe and Oncocytic Tumor Alliance (COA), shared a post on X/Twitter: ''I…
Apr 25, 2024, 21:38 | Blog
Julie Gralow: Busy couple of days on the Hill at ASCO advocacy summit
Julie Gralow recently shared on X/Twitter: ''Busy couple of days on the Hill at ASCO…
Apr 25, 2024, 21:35 | Opinion
Vincent Rajkumar: 10 suggested action items for physician colleagues
Vincent Rajkumar, Editor-in-Chief of Blood Cancer Journal, shared on X/Twitter: ''10 suggested action items for…
Apr 25, 2024, 21:33 | Blog
C. Ola Landgren: It was an honor to present the EVIDENCE meta-analysis at ODAC
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader…
Apr 25, 2024, 21:30 | Blog
Anushka Dongre: Read more about Jason Luke’s work in cancer immunology
Anushka Dongre, Assistant Professor at Cornell University, shared a post on AACR Cancer Immunology Working…
Apr 25, 2024, 21:28 | Blog
Libia Scheller: So honored to be part of this year’s celebration of eMerge Americas
Libia Scheller, Global Head of Oncology- Cooperative Groups and Strategic Alliances at Bayer HealthCare, shared a post on…
Apr 25, 2024, 21:25 | Insight
Paper summary by Erman Akkus on TORCH
Erman Akkus, Medicine Oncology and Internal Medicine Specialist at Ankara University, shared on X: “Deep-learning method…
Apr 25, 2024, 21:12 | Blog
Sumanta K. Pal: World class agenda with terrific speakers
Sumanta K. Pal, Professor and Vice Chair of Academics Affairs at City of Hope shared a…
Apr 25, 2024, 21:09 | Insight
Piotr Wysocki: Salvage re-irradiation is a feasible option in locally recurrent prostate cancer after primary curative radiotherapy
Piotr Wysocki recently shared on LinkedIn: "Locally recurrent prostate cancer (PC) in patients who underwent primary…
Apr 25, 2024, 21:06 | Drugs
Piotr Wysocki: Datopotamab deruxtecan – another anti-TROP2 conjugate demonstrating activity in advanced ER+/HER2- and triple-negative breast cancer patients
Piotr Wysocki recently shared on LinkedIn: "Datopotamab deruxtecan – a novel anti-TROP2 conjugate demonstrates activity…
Apr 25, 2024, 20:59 | Societies
The official opening of the OncoDaily Leukemia Conference took place at the Yeolyan Hematology and Oncology Center
"Today, the official opening of the OncoDaily Leukemia Conference took place at the Yeolyan Hematology…
Apr 25, 2024, 20:52 | Dialogues
Oncothon: Pediatric Cancer Drug Development
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
Apr 25, 2024, 20:46 | Dialogues
Oncothon: APHOG activities and events related to APHOG
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
Apr 25, 2024, 20:28 | Insight
Myeloma Paper of the Day, April 25th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
Apr 25, 2024, 20:18 | Positive
Vivek Subbiah: HUGE MILESTONE in all of medicine and a huge win for patients and families with sickle cell disease and β-Thalassemia
Quoting Vivek Subbiah's post on X/Twitter: "Hot off the press! HUGE MILESTONE in all of…
Apr 25, 2024, 20:14 | Positive
Happy Administrative Professionals Day! - Dana-Farber’s Breast Oncology Center
Quoting Dana-Farber’s Breast Oncology Center on X/Twitter: "Happy Administrative Professionals Day! Today is a reminder…
Apr 25, 2024, 20:06 | Blog
Jacob Adashek: Comparing and contrasting Figures 1 from NRG1 papers from 2020 Clinical Cancer Research of AACR and 2024 BMC Medicine from our paper
Jacob Adashek, Medical Oncology Fellow at the Sidney Kimmel Comprehensive Cancer Center, shared on X/Twitter:…
Apr 25, 2024, 20:01 | Blog
Naveen Pemmaraju: Serious meeting of the heme minds today with Prof. Naveen Pemmaraju and Prof. Jason Westin
Naveen Pemmaraju shared on X: "Co-fellows to Co-Professors together at MD Anderson Cancer Center! Serious…
Apr 25, 2024, 19:57 | Opinion
Wafik S. El-Deiry: Should free medical school tuition in the US have conditions?
Wafik S. El-Deiry, Director of the Legorreta Cancer Center at Brown University, shared on X: "Should…
Apr 25, 2024, 19:53 | Blog
Razelle Kurzrock: SWOG has given us the opportunity to do a national immunotherapy trial for rare tumors
Razelle Kurzrock, Chair of Precision Oncology at MCW Cancer Center, shared a post by SWOG…
Apr 25, 2024, 19:48 | Insight
New Paper Alert! The INNOVATED Cohort: The Role of Immune Checkpoint Blockers in Solid Organ Transplant Recipients with Cancer
The INNOVATED Cohort: The Role of Immune Checkpoint Blockers in Solid Organ Transplant Recipients with…
Apr 25, 2024, 19:47 | Blog
Rob Butcher: Bad weekend for cancer, Good weekend for hope
Rob Butcher, CEO of Cancer Innovation Fund and Swim Across America, shared on LinkedIn: "Bad weekend…
Apr 25, 2024, 19:41 | Blog
Bente Mikkelsen: Each year, approximately 3,043 women in Zimbabwe are diagnosed with cervical cancer
Bente Mikkelsen, Director of NCD at WHO, shared on LinkedIn: "Each year, approximately 3,043 women in…
Apr 25, 2024, 19:36 | Blog
Celebrating National Volunteer Week! - Pediatric Cancer Research Foundation
Pediatric Cancer Research Foundation shared on LinkedIn: "Celebrating National Volunteer Week! The Pediatric Cancer Research Foundation…
Apr 25, 2024, 19:32 | Blog
Janice Cowden: We need your voice
Janice Cowden shared on LinkedIn: "Are you a cancer Patient, Research, Policy or Community advocate? Are…
Apr 25, 2024, 19:26 | Blog
Pat Price: What a humbling and amazing experience, surrounded by 50k runners
Pat Price, Co-Founder of Global Coalition for Radiotherapy, shared on LinkedIn: "What a humbling and amazing…
Apr 25, 2024, 19:25 | Blog
Khalid El Bairi interview with Dr Ouissam Al Jarroudi (MD)
Khalid El Bairi, International Executive Council at NCODA, shared on LinkedIn: "Dr Ouissam Al Jarroudi (MD)…
Apr 25, 2024, 19:18 | Career
Paul Fenton: Excited to welcome Dr. Nat Lenzo to Icon Group
Paul Fenton, CEO of the Cancer Services Australia and New Zealand, shared a post on…
Apr 25, 2024, 19:09 | Blog
Wafik S. El-Deiry: The published version of our paper that’s out as a preprint
Wafik S. El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director…
Apr 25, 2024, 19:01 | Career
Bailee Kain: I am thrilled to announce that I was awarded a 3 year Leukemia and Lymphoma Society CDP fellowship
Bailee Kain, Postdoctoral Researcher in Dr. Lee Grimes's lab at Cincinnati Children's Hospital Medical Center, shared…
Apr 25, 2024, 18:58 | Blog
Herbert Loong: Thanks Harald A. Weber and local Pfizer team for your visit to our Faculty of Medicine of the Chinese University of Hong Kong
Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, shared on X:…
Apr 25, 2024, 18:55 | Blog
Technology in Cancer Research and Treatment is growing its volunteer reviewer pool!
Technology in Cancer Research and Treatment Journal shared on X: "Technology in Cancer Research and…
Apr 25, 2024, 18:50 | Insight
Wafik S. El-Deiry: Very pleased to share bioRxiv pre-print by El-Deiry Lab member and Brown University alumnus William MacDonald
Wafik S. El-Deiry, Director of the Legorreta Cancer Center at Brown University, shared on X:…
Apr 25, 2024, 15:57 | Blog
Join the 14th ACCELERATE Paediatric Strategy Forum
ACCELERATE shared a post on LinkedIn: "Expression of interest is now open! Join us for the…
Apr 25, 2024, 15:48 | Blog
Aydah AlAwadhi: Fatima Dakhil's story embodies strength, patience, hope, resilience, faith, and persistence
Aydah AlAwadhi, Consultant Medical Oncologist at Abu Dhabi Health Services Company (SEHA), shared a post…
Apr 25, 2024, 15:40 | Blog
BioTrinity 2024 in the City of London - The Institute of Cancer Research
The Institute of Cancer Research shared a post on LinkedIn: "Calling companies and potential partners…
Apr 25, 2024, 15:04 | Blog
We thank the Prime Minister Justin Trudeau for listening to their stories and showing support for Daffodil Month - Canadian Cancer Society
Canadian Cancer Society shared a post on LinkedIn: "It was an honour to sit down with…
Apr 25, 2024, 14:55 | Blog
Binay Shah: Binaytara Foundation’s flagship conference SCHD24 is approaching
Binay Shah, President of Binaytara Foundation, shared a post by Binaytara Foundation on LinkedIn: "This is Binaytara…
Apr 25, 2024, 14:48 | Blog
Bernard A. Fox: Guidelines for Optimizing NBTXR3 Nanoparticle Injection in Head and Neck Cancer: A Collaborative Achievement
Bernard A. Fox, Co-Founder and CEO of UbiVac, shared on LinkedIn: "Wonderful to start the week…
Apr 25, 2024, 14:41 | Blog
Cristian Massacesi: I’m proud to share that AstraZeneca was named one of the winners of Bio-IT World's Innovative Practices Awards at Bio-IT Expo in Boston
Cristian Massacesi, Chief Medical Officer and Oncology Chief Development Officer at AstraZeneca, posted on LinkedIn:…
Apr 25, 2024, 14:22 | Blog
The Lung Cancer Policy Network members count more than 70 members from all over the world!
Lung Cancer Policy Network shared on LinkedIn: “We’re thrilled to now count more than 70…
Apr 25, 2024, 14:18 | Career
Gevorg Tamamyan: It is an extreme honor being elected as the President-Elect of SIOP Asia
Gevorg Tamamyan shared on LinkedIn: "It is an extreme honor being elected as the President-Elect of…
Apr 25, 2024, 13:53 | Opinion
Mara Antonoff: So lucky to have friends who are also inspiring role models
Mara Antonoff, Associate Professor of Thoracic and Cardiovascular Surgery at MD Anderson Cancer Center, shared…
Apr 25, 2024, 13:40 | Blog
Marilyn Heine: Thank you James Barbaccia ⁦at Scott Perry for taking time to discuss action items for Congress
Marilyn Heine, Physician at Pennsylvania Medical Society, shared a post on LinkedIn: "Thank you James Barbaccia ⁦at…
Apr 25, 2024, 12:59 | Societies
Chitkala Kalidas: It was a pleasure participating in the industry panel discussion at Cancer Drug Development Forum
Chitkala Kalidas, Vice President, Global Head of Oncology at Bayer shared a post on LinkedIn:…
Apr 25, 2024, 12:40 | Drugs
Piotr Wysocki: Similar activity of topotecan and liposomal irinotecan in second-line treatment of SCLC
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 25, 2024, 12:34 | Societies
Savannah Esteve Morreale: MD Anderson Cancer Center IDEAS Lab team hosted annual Innovation Cadaver Lab
Savannah Esteve Morreale, Surgery Innovation Program Manager at MD Anderson Cancer Center shared a post…
Apr 25, 2024, 12:25 | Societies
Kate O'Regan: Cancer care is not just about medicines
Kate O'Regan, Head of Communications and Stakeholder Relations at Medicines for Europe shared a post…
Apr 25, 2024, 12:10 | Blog
Myriam Chalabi: Very happy to host Ulrike Harjes from Nature Medicine
Myriam Chalabi: Medical Oncologist and Cancer Immunotherapy Researcher at Antoni van Leeuwenhoek, The Netherlands Cancer…
Apr 25, 2024, 12:03 | Insight
Carl Kay: Treatment Algorithm for Managing C. difficile infection in 2024
Carl Kay, Assistant Professor at Uniformed Services University of the Health Sciences, recently shared on…
Apr 25, 2024, 11:55 | Blog
Oncoheroes Biosciences CEO and Co-Founder, Ricardo Garcia, has been featured in the book 'TOP Disruptors - Guide to Entrepreneurs and CEOs Who Stand Out for Their Innovative Talent'
Apr 25, 2024, 11:47 | Blog
Cecilia Monge B.: The Importance of Health Disparities in Liver Cancer in the Hispanic Population
Cecilia Monge B., Safety Review Committee at National Cancer Institute, shared a post on LinkedIn: "The Importance…
Apr 25, 2024, 11:35 | Blog
Alai Goñi Ramirez: Our collaborative work with Naru Intelligence has been selected as a Proffered Paper at Estro meets Asia congress 2024
Alai Goñi Ramirez, radiation oncologist at Onkologikoa, shared a post on LinkedIn: "Delighted to share that…
Apr 25, 2024, 01:16 | Blog
A warm welcome to Nancy Cincotta as our new Chief Psychosocial Officer- Richi Childhood Cancer Foundation
Richi Childhood Cancer Foundation shared a post on LinkedIn: "We’re thrilled to announce a new addition…
Apr 25, 2024, 01:08 | Blog
Idah Phiri: I'm delighted to have represented the Zambian Cancer Society at the recent high-level meeting with the WHO
Idah Phiri, Communications and Administration Manager at Zambian Cancer Society, shared a post on LinkedIn: "I'm…
Apr 25, 2024, 01:01 | Blog
Stéphane Hogan: Please consider responding to this survey on health and care systems
Stéphane Hogan, Head of Unit at Health and Digital Executive Agency, shared a post by THCS…
Apr 25, 2024, 00:53 | Blog
Ruzanna Papyan: Thrilled to have been part of POEM Group and St. Jude Children's Research Hospital collaboration
Ruzanna Papyan, Pediatric Oncologist at Pediatric Cancer and Blood Disorders Center of Armenia, shared a post…
Apr 25, 2024, 00:51 | Insight
New Paper Alert! Nivolumab plus Cabozantinib Maintains Long-Term Survival Benefit in Advanced Renal Cell Carcinoma
Nivolumab plus Cabozantinib Maintains Long-Term Survival Benefit in Advanced Renal Cell Carcinoma Authors: T. Powles,…
Apr 25, 2024, 00:47 | Blog
Karima Oualla: Rich session on GU oncology at ASUUF
Karima Oualla, Professor of Medical Oncology at Hassan II University Hospital, shared a post on LinkedIn:…
Apr 25, 2024, 00:36 | Insight
Allison Rosen: After two years of participating in the AACR Scientist Survivor program this year I got to mentor a group along side the amazing scientific mentor Jerry Lee
Apr 25, 2024, 00:29 | Insight
Shlomit Schaal: Transformational experience at the Harvard T.H. Chan School of Public Health Master in Healthcare Management program
Shlomit Schaal, Executive Vice President and Chief Physician Executive Officer at Houston Methodist Physician Organisation,…
Apr 25, 2024, 00:22 | Blog
Yazan Madanat: Absolutely blown away by Sanam Loghavi's ability to build bridges between clinicians and hematopathologists
Yazan Madanat, Assistant Professor at UTSW Simmons Cancer Center, shared a post on X: "Absolutely blown…
Apr 25, 2024, 00:14 | Blog
Anand Patel: Make sure to sign up for Heme Reports next session!
Anand Patel, Assistant Professor of hematology and oncology at UChicago Medicine, shared a post by Heme…
All: 15996 Posts: 8301 - 8400